Global Hemoglobinopathies Drugs Market Research Report 2019

Table of Contents

Executive Summary

1 Hemoglobinopathies Drugs Market Overview

• 1.1 Product Overview and Scope of Hemoglobinopathies Drugs
• 1.2 Hemoglobinopathies Drugs Segment by Type
  • 1.2.1 Global Hemoglobinopathies Drugs Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Thalassemia Therapy
  • 1.2.3 Sickle Cell Disease(SCD) Therapy
  • 1.2.4 Other Therapy
• 1.3 Hemoglobinopathies Drugs Segment by Application
  • 1.3.1 Hemoglobinopathies Drugs Consumption Comparison by Application (2014-2025)
  • 1.3.2 Alpha Thalassemia
  • 1.3.3 Beta thalassemia
  • 1.3.4 Sickle Cell Disease
  • 1.3.5 Hb Variants Diseases
• 1.3 Global Hemoglobinopathies Drugs Market by Region
  • 1.3.1 Global Hemoglobinopathies Drugs Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Hemoglobinopathies Drugs Market Size
  • 1.4.1 Global Hemoglobinopathies Drugs Revenue (2014-2025)
  • 1.4.2 Global Hemoglobinopathies Drugs Production (2014-2025)

2 Global Hemoglobinopathies Drugs Market Competition by Manufacturers

• 2.1 Global Hemoglobinopathies Drugs Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Hemoglobinopathies Drugs Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Hemoglobinopathies Drugs Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Hemoglobinopathies Drugs Production Sites, Area Served, Product Types
• 2.5 Hemoglobinopathies Drugs Market Competitive Situation and Trends
  • 2.5.1 Hemoglobinopathies Drugs Market Concentration Rate
  • 2.5.2 Hemoglobinopathies Drugs Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Hemoglobinopathies Drugs Production Market Share by Regions

• 3.1 Global Hemoglobinopathies Drugs Production Market Share by Regions
• 3.2 Global Hemoglobinopathies Drugs Revenue Market Share by Regions (2014-2019)
• 3.3 Global Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Hemoglobinopathies Drugs Production
  • 3.4.1 North America Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
  • 3.4.2 North America Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Hemoglobinopathies Drugs Production
  • 3.5.1 Europe Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
  • 3.5.2 Europe Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Hemoglobinopathies Drugs Production (2014-2019)
  • 3.6.1 China Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
  • 3.6.2 China Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Hemoglobinopathies Drugs Production (2014-2019)
  • 3.7.1 Japan Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
  • 3.7.2 Japan Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Hemoglobinopathies Drugs Consumption by Regions

• 4.1 Global Hemoglobinopathies Drugs Consumption by Regions
• 4.2 North America Hemoglobinopathies Drugs Consumption (2014-2019)
• 4.3 Europe Hemoglobinopathies Drugs Consumption (2014-2019)
• 4.4 China Hemoglobinopathies Drugs Consumption (2014-2019)
• 4.5 Japan Hemoglobinopathies Drugs Consumption (2014-2019)

5 Global Hemoglobinopathies Drugs Production, Revenue, Price Trend by Type

• 5.1 Global Hemoglobinopathies Drugs Production Market Share by Type (2014-2019)
• 5.2 Global Hemoglobinopathies Drugs Revenue Market Share by Type (2014-2019)
• 5.3 Global Hemoglobinopathies Drugs Price by Type (2014-2019)
• 5.4 Global Hemoglobinopathies Drugs Production Growth by Type (2014-2019)

6 Global Hemoglobinopathies Drugs Market Analysis by Applications

• 6.1 Global Hemoglobinopathies Drugs Consumption Market Share by Application (2014-2019)
• 6.2 Global Hemoglobinopathies Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Hemoglobinopathies Drugs Business

• 7.1 Gamida Cell
  • 7.1.1 Gamida Cell Hemoglobinopathies Drugs Production Sites and Area Served
  • 7.1.2 Hemoglobinopathies Drugs Product Introduction, Application and Specification
  • 7.1.3 Gamida Cell Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Alnylam Pharmaceuticals
  • 7.2.1 Alnylam Pharmaceuticals Hemoglobinopathies Drugs Production Sites and Area Served
  • 7.2.2 Hemoglobinopathies Drugs Product Introduction, Application and Specification
  • 7.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Biogen Idec
  • 7.3.1 Biogen Idec Hemoglobinopathies Drugs Production Sites and Area Served
  • 7.3.2 Hemoglobinopathies Drugs Product Introduction, Application and Specification
  • 7.3.3 Biogen Idec Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Sangamo BioSciences Inc.
  • 7.4.1 Sangamo BioSciences Inc. Hemoglobinopathies Drugs Production Sites and Area Served
  • 7.4.2 Hemoglobinopathies Drugs Product Introduction, Application and Specification
  • 7.4.3 Sangamo BioSciences Inc. Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Genetix Pharmaceuticals/Bluebird Bio
  • 7.5.1 Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Production Sites and Area Served
  • 7.5.2 Hemoglobinopathies Drugs Product Introduction, Application and Specification
  • 7.5.3 Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Global Blood Therapeutics Inc.
  • 7.6.1 Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Production Sites and Area Served
  • 7.6.2 Hemoglobinopathies Drugs Product Introduction, Application and Specification
  • 7.6.3 Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Pfizer Inc.
  • 7.7.1 Pfizer Inc. Hemoglobinopathies Drugs Production Sites and Area Served
  • 7.7.2 Hemoglobinopathies Drugs Product Introduction, Application and Specification
  • 7.7.3 Pfizer Inc. Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Mast Therapeutics
  • 7.8.1 Mast Therapeutics Hemoglobinopathies Drugs Production Sites and Area Served
  • 7.8.2 Hemoglobinopathies Drugs Product Introduction, Application and Specification
  • 7.8.3 Mast Therapeutics Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Emmaus Life Sciences, Inc.
  • 7.9.1 Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Production Sites and Area Served
  • 7.9.2 Hemoglobinopathies Drugs Product Introduction, Application and Specification
  • 7.9.3 Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Prolong Pharmaceuticals
  • 7.10.1 Prolong Pharmaceuticals Hemoglobinopathies Drugs Production Sites and Area Served
  • 7.10.2 Hemoglobinopathies Drugs Product Introduction, Application and Specification
  • 7.10.3 Prolong Pharmaceuticals Hemoglobinopathies Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Celgene Corporation
• 7.12 HemaQuest Pharmaceuticals

8 Hemoglobinopathies Drugs Manufacturing Cost Analysis

• 8.1 Hemoglobinopathies Drugs Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Hemoglobinopathies Drugs
• 8.4 Hemoglobinopathies Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Hemoglobinopathies Drugs Distributors List
• 9.3 Hemoglobinopathies Drugs Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Hemoglobinopathies Drugs Market Forecast

• 11.1 Global Hemoglobinopathies Drugs Production, Revenue Forecast
  • 11.1.1 Global Hemoglobinopathies Drugs Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Hemoglobinopathies Drugs Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Hemoglobinopathies Drugs Price and Trend Forecast (2019-2025)
• 11.2 Global Hemoglobinopathies Drugs Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Hemoglobinopathies Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Hemoglobinopathies Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Hemoglobinopathies Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Hemoglobinopathies Drugs Production, Revenue Forecast (2019-2025)
• 11.3 Global Hemoglobinopathies Drugs Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Hemoglobinopathies Drugs Consumption Forecast (2019-2025)
  • 11.3.2 Europe Hemoglobinopathies Drugs Consumption Forecast (2019-2025)
  • 11.3.3 China Hemoglobinopathies Drugs Consumption Forecast (2019-2025)
  • 11.3.4 Japan Hemoglobinopathies Drugs Consumption Forecast (2019-2025)
• 11.4 Global Hemoglobinopathies Drugs Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Hemoglobinopathies Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List